Dispelling the Myths of Canine Cancer and Its Treatment

associated with the duration of first remission in canine lymphoma patients treated with standard of care doxorubicin-based chemotherapy. These data have been validated in an independent study population and used to develop a cytogenetic test to predict how long dogs diagnosed with lymphoma will respond to doxorubicin-based therapy. ................
................